Reduced inflammation following human endometrial stromal/stem cell injection into male Wistar rats with cisplatin-induced acute kidney injury

Hadis Zeinali ¹ , Mahnaz Azarnia ¹ * , Peyman Keyhanvar ^2,3 * , Reza Moghadasali ⁴, Somayeh Ebrahimi-Barough ⁵, Majid Marandi-Kouchaki ¹

Cited by CrossRef: 3

1- Motwani S, Sandhu S, Kitchlu A. Cisplatin Nephrotoxicity: Novel Insights Into Mechanisms and Preventative Strategies. Seminars in Nephrology. 2022;42(6):151341 [Crossref]

2- Liang J, Li B, Xia Y. MicroR-380-3p Reduces Sepsis-Induced Acute Kidney Injury via Regulating RAB1P to Restrain NF-κB Pathway. Tohoku J Exp Med. 2024;263(1):69 [Crossref]

3- Liao S, Zhang X, Zhou Y, Wang L, Chen C, Ye C, Zhou Y, Wang C. Worldwide hotspots and trends in stem cell therapy for kidney disease in the last decade: a bibliometric and visualization analysis from 2015 to 2024. Front Immunol. 2025;16 [Crossref]

4- Liu J, Li Z, Lao Y, Jin X, Wang Y, Jiang B, He R, Yang S. Network pharmacology, molecular docking, and experimental verification reveal the mechanism of San-Huang decoction in treating acute kidney injury. Front Pharmacol. 2023;14 [Crossref]

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate (2024): 20%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded; Google Scholar; SJR; Essential Science Indicators; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO
Member of
Follower of ICMJE
Permission: Creative Commons